SciSparc (NASDAQ: SPRC) regains Nasdaq compliance but faces future test
Rhea-AI Filing Summary
SciSparc Ltd. reports that Nasdaq has issued a conditional compliance letter confirming the company now meets Nasdaq Continued Listing Rule 5550(b)(1) based on its Form 20-F for the year ended December 31, 2025. This resolves an earlier notice that SciSparc failed to satisfy the minimum $2,500,000 stockholders’ equity requirement or the alternative market value and net income tests.
Nasdaq’s staff cautions that if SciSparc does not demonstrate ongoing compliance when it files its next periodic report, the company may face delisting. The 6-K is also incorporated by reference into multiple existing Form F-3 and Form S-8 registration statements.
Positive
- Nasdaq compliance restored: Nasdaq staff has determined SciSparc now complies with Continued Listing Rule 5550(b)(1), removing the immediate threat of delisting tied to earlier shortfalls in stockholders’ equity and related alternative tests.
Negative
- None.
Insights
SciSparc regains Nasdaq compliance but must maintain key financial thresholds.
SciSparc previously failed Nasdaq Rule 5550(b) because it did not meet the minimum $2,500,000 stockholders’ equity requirement or alternative market value and net income standards. Nasdaq staff now considers the company compliant with Rule 5550(b)(1) based on its Form 20-F for the year ended December 31, 2025.
This removes immediate delisting pressure but keeps a clear condition: if the next periodic report does not evidence continued compliance, Nasdaq staff may pursue delisting. The impact for shareholders hinges on SciSparc sustaining balance sheet metrics that satisfy Rule 5550(b) in upcoming filings.
The 6-K is incorporated by reference into several Form F-3 and Form S-8 registration statements, so any future change in listing status or compliance could also affect the flexibility and perception of those registered securities, depending on how the company’s financial position evolves.